Skip Navigation

European Heart Journal 1990 11(11):997-1005;
Copyright © 1990 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by SERVI, S. D.
Right arrow Articles by SPECCHIA, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SERVI, S. D.
Right arrow Articles by SPECCHIA, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 The European Society of Cardiology

Variable response to atrial pacing after intravenous propranolol in patients with stable exertional angina

S. DE SERVI, M. FERRARIO, S. GHIO, P. CIOFFI, L. ANGOLI, E. BRAMUCCI, E. AIMÈ, V. MONTERICCIO and G. SPECCHIA

Divisione di Cardiologia IRCCS, Policlinico S. Matteo Pavia, Italy

Received 20 March 1989; revised 30 October 1989; .

Address for correspondence: Stefano De Servi, MD, Divisione di Cardiologia Policlinico S. Matteo 27100 Pavia, Italy.

Abstract

The effect of propranolol administration on regional coronary haemodynamics were investigated in 14 patients with stable exertional angina and isolated left anterior descending artery disease. Thermodilution was used to measure great cardiac vein flow (GCVF) and anterior regional coronary resistance (ARCR) under control conditions, at peak atrial pacing, after i. v. propranolol administration (0.1 mgkg–1) and at the peak of repeated atrial pacing.

Propranolol did not change peak pacing heart rate, systolic blood pressure or double product. Peak pacing GCVF decreased slightly but non-significantly after drug administration from 84±20 to 79±24 ml min–1, while ARCR increased, but again non-significantly, from I.36±0.44 to 1.45±0.45. Analysis of individual patient responses revealed that propranolol prolonged peak pacing time and hence peak pacing heart rate (from 126±24 to 140±23 beats min–1, P<0.05) in five patients. In such patients, peak pacing systolic blood pressure was lower than the pre-propranolol atrial pacing (145±35 vs 165±33, P<0.001) so that double product remained unchanged. Moreover, peak pacing ARCR did not change after propranolol (pre-propranolol 1.47±0.46, after propranolol 1.40±0.56mmHg. ml–1.min, P = ns) while it increased significantly in the nine patients who did not improve after the drug (before propranolol 1.30±0.44, after propranolol 1.48±0.41 mmHg. ml–1.min, P<0.02).

These data suggest that the response to atrial pacing after i. v. propranolol administration is variable as some patients tolerate higher heart rates while others do not. Such variability may depend on different effects of the drug on coronary haemodynamics and on factors affecting myocardial oxygen consumption.

Key Words: Angina pectoris • atrial pacing • coronary haemodynamics • propranolol


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.